DEPACON Side Effects

6917820-1 | Hepatic Enzyme Increased, Status Epilepticus
on Aug 06, 2010 Male patient from PHILIPPINES , child 6 years of age, weighting 88.18 lb, was diagnosed with convulsion and was treated with Depacon (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, status epilepticus. Depacon dosage: 12mg/kg For 1 Hour Infusion (480mg/hour).

6888822-9 | Hepatic Enzyme Increased, Status Epilepticus
Patient was taking Depacon (View Usage). Patient had the following side effects: hepatic enzyme increased, status epilepticus on Jul 22, 2010 from PHILIPPINES Additional patient health information: Male patient , child 6 years of age, weighting 88.18 lb, was diagnosed with febrile convulsion and. Depacon dosage: .

6762661-1 | Overdose
Adverse event was reported on Jun 01, 2010 by a Female patient taking Depacon (View Usage) (Dosage: 500 Mg Daily) was diagnosed with convulsion and. Location: PHILIPPINES , weighting 12.13 lb, After Depacon was administered, patient had the following side effects: overdose. Patient was hospitalized.

6410725-4 | Activities Of Daily Living Impaired, Apallic Syndrome, Gait Disturbance
on Oct 12, 2009 Female patient from UNITED STATES , weighting 190.2 lb, was diagnosed with convulsion and was treated with Depacon (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, apallic syndrome, gait disturbance. Depacon dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).


6387009-6 | Acidosis
on Sep 25, 2009 Male patient from UNITED STATES , 32 years of age, weighting 240.3 lb, was diagnosed with prophylaxis, nervous system disorder and was treated with Depacon (View Usage). Patient had the following side effects: acidosis. Depacon dosage: Bolus: 15mg/kg/163 Mg/100.

6369159-3 | Acidosis, Haemodynamic Instability, Procedural Complication, Ventricular Fibrillation
Patient was taking Depacon (View Usage). After Depacon was administered, patient had the following side effects: acidosis, haemodynamic instability, procedural complication, ventricular fibrillation on Sep 18, 2009 from UNITED STATES Additional patient health information: Male patient , 32 years of age, weighting 240.3 lb, . Depacon dosage: Bolus:15mg/kg,1635 Mg/100. During the same period patient was treated with INTRAOPERATIVE AGENTS GIVEN: VERSED (View Intraoperative Agents Given: Versed Review and Intraoperative Agents Given: Versed Label ), VENTANYL (View Ventanyl Review and Ventanyl Label ), PROPOFOL (View Propofol Review and Propofol Label ), PANCURONIUM (View Pancuronium Review and Pancuronium Label ), HEPARIN (View Heparin Review and Heparin Label ), AMICAR (View Amicar Review and Amicar Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ).

6360406-0 | Acidosis
Adverse event was reported on Sep 11, 2009 by a Male patient taking Depacon (View Usage) (Dosage: Bolus: 15mg/kg/163 Mg/100) was diagnosed with prophylaxis, nervous system disorder and. Location: UNITED STATES , 32 years of age, weighting 240.3 lb, Patient experienced the following unwanted or unexpected effects: acidosis.

6356898-3 | Acidosis, Blood Pressure Abnormal, Haemodynamic Instability, Ventricular Fibrillation
on Sep 10, 2009 Male patient from UNITED STATES , 32 years of age, weighting 240.3 lb, was treated with Depacon (View Usage). Patient had the following side effects: acidosis, blood pressure abnormal, haemodynamic instability, ventricular fibrillation. Depacon dosage: Bolus: 15mg/kg. 1635mg/100.

6349787-1 | Acidosis
on Sep 04, 2009 Male patient from UNITED STATES , 32 years of age, weighting 220.5 lb, was diagnosed with prophylaxis, nervous system disorder and was treated with Depacon (View Usage). After Depacon was administered, patient had the following side effects: acidosis. Depacon dosage: Bolus: 15mg/kg/163 Mg/100.

6049138-6 | Ammonia Increased, Coma, Grand Mal Convulsion, Metabolic Acidosis, Renal Impairment
Patient was taking Depacon (View Usage). Patient experienced the following unwanted or unexpected effects: ammonia increased, coma, grand mal convulsion, metabolic acidosis, renal impairment on Apr 02, 2008 from UNITED STATES Additional patient health information: Female patient , 42 years of age, was diagnosed with convulsion and. Depacon dosage: . During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ), TERGETOL (View Tergetol Review and Tergetol Label ). Patient was hospitalized.

6049129-5 | Liver Function Test Abnormal
Adverse event was reported on Jan 15, 2008 by a Male patient taking Depacon (View Usage) (Dosage: ) . Location: UNITED STATES , 17 years of age, Patient had the following side effects: liver function test abnormal.

5677592-8 | Amnesia, Cold Sweat, Gait Disturbance, Migraine, Pain
on Jun 20, 2007 Female patient from UNITED STATES , weighting 160.1 lb, was diagnosed with migraine (What is migraine?), thrombosis prophylaxis, headache (What is headache?), blood pressure (What is blood pressure?) and was treated with Depacon (View Usage). After Depacon was administered, patient had the following side effects: amnesia, cold sweat, gait disturbance, migraine (What is migraine?), pain (What is pain?). Depacon dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), METAXALONE (View Metaxalone Review and Metaxalone Label ).

5489581-7 | Encephalopathy
on Oct 16, 2007 Female patient from UNITED STATES , 17 years of age, weighting 172.0 lb, was diagnosed with convulsion and was treated with Depacon (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy. Depacon dosage: 2 - 6 Mg/kg/hour Iv Drip. Patient was hospitalized.

5408862-6 | Blister, Erythema, Musculoskeletal Pain, Oedema Peripheral, Rash
Patient was taking Depacon (View Usage). Patient had the following side effects: blister, erythema, musculoskeletal pain, oedema peripheral, rash (What is rash?) on Aug 03, 2007 from FRANCE Additional patient health information: Male patient , 48 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Depacon dosage: . During the same period patient was treated with HEPARIN FRACTION, SODIUM SALT (View Heparin-fraction, Sodium Salt Review and Heparin-fraction, Sodium Salt Label ). Patient was hospitalized.

5342043-X | Aggression, Mania, Mental Disorder, Oedema Peripheral, Toxic Epidermal Necrolysis, Urticaria
Adverse event was reported on May 30, 2007 by a Male patient taking Depacon (View Usage) (Dosage: Iv) was diagnosed with mania, psychotic disorder (What is psychotic disorder?) and. Location: UNITED STATES , 57 years of age, weighting 250.0 lb, After Depacon was administered, patient had the following side effects: aggression, mania, mental disorder, oedema peripheral, toxic epidermal necrolysis, urticaria. Patient was hospitalized and became disabled.

5313275-1 | Agitation, Hallucination, Rash
on Jan 23, 2006 Male patient from UNITED STATES , 18 years of age, was diagnosed with convulsion and was treated with Depacon (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, hallucination, rash (What is rash?). Depacon dosage: . During the same period patient was treated with PHENYTOIN SODIUM (View Phenytoin Sodium Review and Phenytoin Sodium Label ).

5112558-8 | Blister, Erythema, Musculoskeletal Pain, Oedema Peripheral, Rash
on Sep 11, 2006 Male patient from FRANCE , 48 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Depacon (View Usage). Patient had the following side effects: blister, erythema, musculoskeletal pain, oedema peripheral, rash (What is rash?). Depacon dosage: . During the same period patient was treated with HEPARIN FRACTION, SODIUM SALT (View Heparin-fraction, Sodium Salt Review and Heparin-fraction, Sodium Salt Label ). Patient was hospitalized.

5011248-X | Ammonia Increased, Depressed Level Of Consciousness
Patient was taking Depacon (View Usage). After Depacon was administered, patient had the following side effects: ammonia increased, depressed level of consciousness on May 23, 2006 from UNITED STATES Additional patient health information: Female patient , 15 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Depacon dosage: 1200mg Loading Dose Q6h Iv Bolus. Patient was hospitalized and became disabled.

4960920-6 | Pancreatitis Haemorrhagic
Adverse event was reported on Dec 14, 2004 by a Female patient taking Depacon (View Usage) (Dosage: 1 Gm, Once, Then 750 Mg To 1 Gm Tid, Intravenous) was diagnosed with status epilepticus, subdural haematoma and. Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: pancreatitis haemorrhagic. During the same period patient was treated with FOSPHENYTOIN SODIUM (View Fosphenytoin Sodium Review and Fosphenytoin Sodium Label ).

4882468-X | Encephalopathy, Leukodystrophy, Motor Dysfunction, Mutism, Staphylococcal Bacteraemia, Unevaluable Event
on Nov 24, 2003 Female patient from FRANCE , 79 years of age, was treated with Depacon (View Usage). Patient had the following side effects: encephalopathy, leukodystrophy, motor dysfunction, mutism, staphylococcal bacteraemia, unevaluable event. Depacon dosage: . During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), PIP/TAZO (View Pip/tazo Review and Pip/tazo Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), CLINDAMYCIN PHOSPHATE (View Clindamycin Phosphate Review and Clindamycin Phosphate Label ). Patient was hospitalized.

4882386-7 | Encephalopathy, Leukodystrophy, Motor Dysfunction, Mutism, Staphylococcal Bacteraemia, Unevaluable Event
on Nov 24, 2003 Female patient from FRANCE , 79 years of age, was treated with Depacon (View Usage). After Depacon was administered, patient had the following side effects: encephalopathy, leukodystrophy, motor dysfunction, mutism, staphylococcal bacteraemia, unevaluable event. Depacon dosage: . During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), PIP/TAZO (View Pip/tazo Review and Pip/tazo Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), CLINDAMYCIN PHOSPHATE (View Clindamycin Phosphate Review and Clindamycin Phosphate Label ). Patient was hospitalized.

4704089-1 | Cerebrovascular Arteriovenous Malformation, Pancytopenia
Patient was taking Depacon (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular arteriovenous malformation, pancytopenia on Jun 02, 2005 from Additional patient health information: Female patient , 21 years of age, was diagnosed with convulsion prophylaxis, pyrexia and. Depacon dosage: 1500.0 Mg (500.0 Mg, 3 In 1 D) Intravenous. During the same period patient was treated with CLORAZEPATE DIPOTASSIUM (10.0 Mg (10.0 Mg, 1 In 1 D) Oral) (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label ), METAMIZOLE MAGNESIUM (2.0 Mg, 3 In 1 D Intravenous) (View Metamizole Magnesium Review and Metamizole Magnesium Label ), OMEPRAZOLE (40.0 Mg (40.0 Mg, 1 In 1 D)) (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN (4.0 Gm, 4 In 1 D Intravenous) (View Acetaminophen Review and Acetaminophen Label ), KETOROLAC TROMETHAMINE (90.0 Mg, 3 In 1 D Intravenous) (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), BUPRENORPHINE HCL (View Buprenorphine Hcl Review and Buprenorphine Hcl Label ), ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label ). Patient was hospitalized.

4559770-4 | Pancreatitis Haemorrhagic
Adverse event was reported on Sep 21, 2004 by a Female patient taking Depacon (View Usage) (Dosage: Intravenous) was diagnosed with status epilepticus and. Location: , 47 years of age, Patient had the following side effects: pancreatitis haemorrhagic.